Cite
HARVARD Citation
Bradshaw, D. et al. (2020). Protocol for a phase IV, open-label feasibility study investigating non-invasive markers of hepatic fibrosis in people living with HIV-1 and non-alcoholic fatty liver disease randomised to receiving optimised background therapy (OBT) plus maraviroc or OBT alone. BMJ open. 10 (7), p. . [Online].